stella
beta
Nemolizumab to Treat Lichen Planopilaris, a Noncontrolled, Prospective, Pilot Study. — Stella
Recruiting
Back to Lichen Plano-Pilaris trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(1 site)
United States
The Skin Center Dermatology Group, New City, New York
View full record on ClinicalTrials.gov